DeCode s Shares Rebound After Mid-day Dip Following Positive Drug Data

genomeweb
360dx

DeCode s Shares Rebound After Mid-day Dip Following Positive Drug Data

Oct 20, 2004

This article has been updated from a previous version. Share prices have been updated.

To read the full story....

...and receive Daily News bulletins.

Already have an account?
Login Now.

Breaking News

Roche to Close NimbleGen Site, Lay Off 79 by Mid-2020
New Products Posted to GenomeWeb: Thermo Fisher Scientific, Twist Bioscience, 10X Genomics, More
LexaGene Announces C$5M Bought Deal Financing
Large Study Uncovers Genetic Connections Between Numerous Psychiatric Disorders
Cigna to Cover GenomeDx's Decipher Prostate Cancer Tests
Nightingale, UK Biobank to Analyze Metabolomic Markers in 500K Blood Samples

The Scan

Privacy Policy Information, Please

Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.

Moving the Parts About

The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.

This Week in Science

In Science this week: genetic overlap among many psychiatric disorders, and more.

Just Skip that Step

The Economist writes that an increasing number of scientific journals don't do peer review.

Main menu